SEP 24, 2019 7:00 PM PDT

Promising Drug for Prostate Cancer

WRITTEN BY: Nouran Amin

Using high-throughput screening methods, cancer researchers from the UK have identified some promising drug candidates to test thousands of molecules. Specifically, they studied a protein called-methylacyl-CoA racemase (AMACR) as a potential target for therapeutics in prostate cancers. The experiments show that reducing the AMACR protein makes cancer cells less aggressive and allows their behavior to be like normal cells.

“The protein AMACR has been shown to be present in larger quantities in aggressive prostate cancer cells, and this research group have successfully developed a technique to find the protein and monitor its activity. Further to this, they have now found certain compounds that can target this protein's activity in the lab, and stop the cancer cells in their tracks,” says Simon Grieveson, Head of Research Funding at Prostate Cancer UK.

The study examined more than 20,000 drug-like molecules that inhibit the activity of AMACR using a method known as simple color-change technique. The technique allows for quick assessment of active compounds and identification of new types of drugs. Findings were published in the journal Bioorganic Chemistry.

Lead author Dr Matthew Lloyd said: "Although previously identified drugs are very effective in laboratory tests, in practice they are difficult to use in therapies because their properties do not allow easy distribution throughout the body. We started this study because we wanted to identify drugs which would be easier to use therapeutically. Although the particular compounds identified in this study did not kill prostate cancer cells very effectively, it is very promising that drug-like molecules were identified,” says lead author of the study, Dr. Matthew Lloyd rom the University of Bath.

Learn more about prostate cancer:

“The research is still in its infancy and is some way off from clinical investigation, however this is certainly promising and we look forward to seeing how this research progresses over the coming years,” says Grieveson.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUN 07, 2020
Cannabis Sciences
JUN 07, 2020
Should You Smoke Cannabis Seeds and Stems?
When smoking cannabis, people typically use either the flower, buds, or leaves. But what about the seeds and stems? Can ...
JUN 09, 2020
Drug Discovery & Development
JUN 09, 2020
Psychedelic DMT Improves Wellbeing in 89% of People
DMT is a powerful psychedelic drug known to produce visions involving 'other beings' like elves, aliens, and dei ...
JUN 10, 2020
Drug Discovery & Development
JUN 10, 2020
FDA Approves New Antibiotic for Hospital-Acquired Pneumonia
The US Food and Drug Administration (FDA) has approved Recarbrio, an antibiotic drug created by pharmaceutical company M ...
JUN 14, 2020
Chemistry & Physics
JUN 14, 2020
Why Are There So Few Black People in STEM?
On June 10th, 2020, thousands of STEM scientists and organizations around the world went on strike to protest systemic r ...
JUN 03, 2020
Drug Discovery & Development
JUN 03, 2020
Metformin Understood
Metformin is a popular diabetic drug that’s been in use for 60+ years. Researchers have long been baffled on the m ...
JUN 07, 2020
Drug Discovery & Development
JUN 07, 2020
Repurposing An Antibiotic To Defeat a Deadly Superbug
A recent study published in Nature Microbiology describes how an old antibiotic used for Tuberculosis can be powerful tr ...
Loading Comments...